Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


01.09.2025

2 Am J Hematol
2 Ann Hematol
3 Blood
4 Br J Haematol
1 Cancer
1 Cancer Res
1 Int J Hematol
7 Leukemia
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. JEN WY, Loghavi S, Bazinet A, Bataller A, et al
    Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies.
    Am J Hematol. 2025 Aug 28. doi: 10.1002/ajh.70046.
    PubMed        

  2. GOULART H, Jabbour E, Short N, Jain N, et al
    Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy-Based Regimens.
    Am J Hematol. 2025 Aug 27. doi: 10.1002/ajh.70048.
    PubMed        


    Ann Hematol

  3. LAZZAROTTO D, Testi AM, Fanin M, Mosna F, et al
    Pegaspargase administration and tolerability in patients aged 55 years or older with acute lymphoblastic leukemia treated with the LAL1913 program. A subanalysis of the Campus ALL group.
    Ann Hematol. 2025 Aug 27. doi: 10.1007/s00277-025-06550.
    PubMed         Abstract available

  4. RAJENDRA KURUP A, Malcolmson J, Villani A, Kim RH, et al
    Rare germline ETV6 variant associated with thrombocytopenia and acute leukemia.
    Ann Hematol. 2025 Aug 27. doi: 10.1007/s00277-025-06536.
    PubMed         Abstract available


    Blood

  5. CRISPINO JD
    Meddling with METTL3 in acute megakaryoblastic leukemia.
    Blood. 2025;146:1035-1036.
    PubMed        

  6. GEYER MB, DeWolf S, Mi X, Weis K, et al
    CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia.
    Blood. 2025 Aug 27:blood.2025029532. doi: 10.1182/blood.2025029532.
    PubMed         Abstract available

  7. O'BRIEN C, Nursimulu N, Tyagi A, Culp-Hill R, et al
    Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia.
    Blood. 2025 Aug 26:blood.2025029132. doi: 10.1182/blood.2025029132.
    PubMed         Abstract available


    Br J Haematol

  8. NACHTKAMP K, Schulz F, Gattermann N, Germing U, et al
    Clinical management of CMML-State of the art.
    Br J Haematol. 2025;207:350-364.
    PubMed         Abstract available

  9. SAVONA MR, Odenike O, Roboz GJ, Amin H, et al
    Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.
    Br J Haematol. 2025;207:432-444.
    PubMed         Abstract available

  10. KONUMA T, Shimomura Y, Mizuno S, Yamasaki S, et al
    Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantat
    Br J Haematol. 2025;207:484-497.
    PubMed         Abstract available

  11. XIAO J, Xia Y, Yin F, Shi Z, et al
    Global spatiotemporal distribution characteristics and regional risk stratification model of acute myeloid leukaemia based on molecular genetics and cytogenetic features.
    Br J Haematol. 2025;207:395-406.
    PubMed         Abstract available


    Cancer

  12. KAO HW, Chang H, Kuo MC, Wu JH, et al
    Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples.
    Cancer. 2025;131:e70048.
    PubMed         Abstract available


    Cancer Res

  13. SU Y, Li S, Wang L, Wang Y, et al
    Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.
    Cancer Res. 2025 Aug 29. doi: 10.1158/0008-5472.CAN-24-3659.
    PubMed         Abstract available


    Int J Hematol

  14. ONO K, Horiguchi H, Iyama S, Sato K, et al
    Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms.
    Int J Hematol. 2025;122:400-412.
    PubMed         Abstract available


    Leukemia

  15. CURIK N, Laznicka A, Krizkova J, Suchankova P, et al
    Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia.
    Leukemia. 2025 Aug 26. doi: 10.1038/s41375-025-02732.
    PubMed        

  16. HLEIHEL R, Skayneh H, Wu HC, Hamie M, et al
    Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.
    Leukemia. 2025 Aug 26. doi: 10.1038/s41375-025-02731.
    PubMed         Abstract available

  17. RONNACKER J, Muller PJ, Mikesch JH, Zukunft S, et al
    Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.
    Leukemia. 2025;39:2174-2180.
    PubMed         Abstract available

  18. BERTOLI R, Cao D, Tuckey O, Gammell S, et al
    5-Azacytidine and decitabine induce C > G transversions in both murine and human cells.
    Leukemia. 2025;39:2112-2124.
    PubMed         Abstract available

  19. VICK EJ, Hassan A, Choi K, Bennett J, et al
    Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization.
    Leukemia. 2025;39:2163-2173.
    PubMed         Abstract available

  20. CALDERON AS, Ghazanfari R, Masoumi Z, Kharazi S, et al
    Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state.
    Leukemia. 2025;39:2099-2111.
    PubMed         Abstract available

  21. NADEU F, Shuai S, Clot G, Hilton LK, et al
    Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.
    Leukemia. 2025;39:2076-2086.
    PubMed         Abstract available


    PLoS One

  22. SAMI KHAFAGA D, El-Kenawy EM, Rizk FH, Eid MM, et al
    Ocotillo optimization-driven deep learning for bone marrow cytology classification.
    PLoS One. 2025;20:e0330228.
    PubMed         Abstract available

  23. NAVAKANITWORAKUL R, Saelue P, Penglong T, Molika P, et al
    Exosomal miRNA expression profiling in patients with imatinib resistant Chronic myeloid leukemia: A pilot study.
    PLoS One. 2025;20:e0331479.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.